Standout Papers
- Efficacy and Safety of Valganciclovir vs. Oral Ganciclovir for Prevention of Cytomegalovirus Disease in Solid Organ Transplant Recipients (2004)
- Increasing Echinocandin Resistance in Candida glabrata: Clinical Failure Correlates With Presence of FKS Mutations and Elevated Minimum Inhibitory Concentrations (2013)
- Maribavir for Refractory Cytomegalovirus Infections With or Without Resistance Post-Transplant: Results From a Phase 3 Randomized Clinical Trial (2021)
Immediate Impact
2 by Nobel laureates 21 from Science/Nature 83 standout
Citing Papers
The hyphal-specific toxin candidalysin promotes fungal gut commensalism
2024 StandoutNature
Letermovir vs Valganciclovir for Prophylaxis of Cytomegalovirus in High-Risk Kidney Transplant Recipients
2023 Standout
Works of Barbara D. Alexander being referenced
Pharmacodynamics of Oral Ganciclovir and Valganciclovir in Solid Organ Transplant Recipients
2005
Efficacy and Safety of Valganciclovir vs. Oral Ganciclovir for Prevention of Cytomegalovirus Disease in Solid Organ Transplant Recipients
2004 Standout
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Barbara D. Alexander | 6830 | 6261 | 804 | 986 | 176 | 9.8k | |
| B. Dupont | 6103 | 6541 | 460 | 867 | 186 | 9.0k | |
| William G. Merz | 4667 | 5873 | 704 | 1116 | 142 | 7.9k | |
| George R. Thompson | 5910 | 6510 | 771 | 533 | 292 | 9.4k | |
| John W. Baddley | 5601 | 5481 | 471 | 470 | 176 | 8.7k | |
| Katrien Lagrou | 5827 | 6753 | 794 | 483 | 287 | 8.8k | |
| Raleigh A. Bowden | 7568 | 5758 | 675 | 2574 | 96 | 11.2k | |
| Márcio Nucci | 6617 | 7826 | 810 | 1576 | 232 | 11.1k | |
| John R. Graybill | 10540 | 10723 | 626 | 728 | 255 | 14.0k | |
| L. Joseph Wheat | 8214 | 7240 | 493 | 425 | 208 | 9.6k | |
| Michail S. Lionakis | 4044 | 5280 | 551 | 820 | 211 | 9.4k |
All Works
Login with ORCID to disown or claim papers
Loading papers...